1. Montalban X, Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, et al.Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.Lancet Neurol. 2025;24(10):850–865.doi:10.1016/S1474-4422(25)00270-4
2. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al.Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.Lancet Neurol. 2018;17(2):162–173.doi:10.1016/S1474-4422(17)30470-2
3. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al.Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria.Ann Neurol. 2005;58(6):840–846.doi:10.1002/ana.20703
4. ECTRIMS.2024 revisions of the McDonald criteria. Copenhagen; September 2024.[Internet]. Available from: https://ectrims.euAccessed April 26, 2025.
5. Levraut M , Landes-Château C, Mondot L, Cohen M, Lebrun-Frenay C. Kappa serbest hafif zincir indeksi ve santral ven işareti: Multipl skleroz tanısı için iki yeni biyobelirteç. Neurol Ther . 2025 ;14:711–731. doi:10.1007/s40120-025-00737-7
6. Comabella M , Pappolla A, Monreal E, Fissolo N, Sao-Avilés AC, Arrambide G, ve diğerleri. Kan biyobelirteçlerinin multipl skleroz tanısına katkısı. Nörol Nöroimmünol Nöroinflamm . 2025 ;12:e200370. doi:10.1212/NXI.0000000000200370